{"prompt": "['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 78 of 115', 'Version 4, 10NOV2016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 79 of 115', 'Version 4, 10NOV2016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 80 of 115', '19. Ethics', '19.1. Statement(s) of Compliance', 'The study will be conducted in compliance with international ethical and scientific quality standards, known', 'as good clinical practice (GCP). GCP includes review and approval by an independent Ethics', 'Board/Institutional Review Board (IRB)/Medical Ethics Committee (MEC)/Head of Medical Institution (HOMI)', 'before initiating a study, continuing review of an ongoing study by an Ethics Board, and obtaining and', 'documenting the freely given informed consent of a subject before initiating the study.', 'The study was designed to reflect the GCP principles outlined in ISO 14155:2011 and other international', 'clinical requirements outlined below. These include the protection of the rights, safety and well-being of', 'human subjects, controls to ensure the scientific conduct and credibility of the clinical investigation and the', 'definition of responsibilities of the sponsor and Investigators. In accordance with ISO standard, the sponsor', 'shall avoid improper influence on, or inducement of, the subject, monitor, any Investigator(s) or other parties', 'participating in or contributing to the clinical investigation. All Investigators shall avoid improper influence on', 'or inducement of the subject, sponsor, monitor, other Investigator(s) or other parties participating in or', 'contributing to the clinical investigation. The ISO standard also informed study design in the areas of device', 'deficiency reporting and risk evaluation, with the exception (to Section 6.4 of the ISO standard) that only', 'those Adverse Events (AEs) which are cardiovascular, serious, system (cryoablation and', ') related and procedure related will be collected. This ensures any AEs which could', 'potentially be relevant will be collected. There is a second exemption (to Section 18.1 of the ISO standard)', 'that device accountability will not be performed in Europe or Canada and only upon package opening in the', 'US (full device accountability will take place in Japan starting with distribution).', 'The study will be conducted according to federal, national and local laws, regulations, standards, and', 'requirements of the countries/geographies where the study is being conducted. In Europe, the study will', 'also be conducted in accordance with the Declaration of Helsinki 2013. For all geographies, the principles of', 'the Declaration of Helsinki have been implemented through the patient informed consent (IC) process,', 'Ethics Board/IRB/MEC approval, study training, clinical trial registration, preclinical testing, risk-benefit', 'assessment and publication policy.', 'Version 4, 10NOV2016', 'Confidential']\n\n###\n\n", "completion": "END"}